Evidence map›Paper›PMID 39969702›Full record

ArticleImmunologic research2025

Lithospermic acid targeting heat shock protein 90 attenuates LPS-induced inflammatory response via NF-кB signalling pathway in BV2 microglial cells.

Jie Guo, Chen-Guang Li, Feng-Yi Mai, Jing-Rong Liang, Ze-Hao Chen, Jiao Luo, Ming-Chao Zhou, Yu-Long Wang, Wen-Tao Yang

Abstract read
In one paragraph

Article in Immunologic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Computational Analysis andCurrent medicinal chemistry · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jie Guo *Department of Rehabilitation Medicine, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
Chen-Guang Li *Pain Department, Huazhong University of Science and Technology Union Shenzhen Hospital (Nanshan Hospital), Shenzhen, 518052, China.
Feng-Yi Mai *Department of Human Cell Biology and Genetics, Southern University of Science and Technology School of Medicine, Shenzhen, 518055, China.
Jing-Rong LiangPain Department, Huazhong University of Science and Technology Union Shenzhen Hospital (Nanshan Hospital), Shenzhen, 518052, China.
Ze-Hao ChenPain Department, Huazhong University of Science and Technology Union Shenzhen Hospital (Nanshan Hospital), Shenzhen, 518052, China.
Jiao LuoDepartment of Rehabilitation Medicine, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
Ming-Chao ZhouDepartment of Rehabilitation Medicine, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
Yu-Long WangDepartment of Rehabilitation Medicine, Shenzhen Second People's Hospital, Shenzhen, 518035, China. ylwang688@163.com.
Wen-Tao YangPain Department, Huazhong University of Science and Technology Union Shenzhen Hospital (Nanshan Hospital), Shenzhen, 518052, China. yangwentao3000@126.com.

Funding

Basic and Applied Basic Research Foundation of Guangdong Province No.2023A1515110466National Natural Science Foundation of China No.82305387National Natural Science Foundation of China No.82404670Shenzhen Nanshan District Health System Science and Technology Major Project Outstanding Youth Fund No. NSZD2024035Shenzhen Science and Technology R&D Fund Basic Research Project No. JCYJ20220530150407015Shenzhen Science and Technology R&D Fund Basic Research Project No. JCYJ20230807115813028
6 · The paper itself

Abstract

Microglia function as a vital constituent in the maintenance of brain homeostasis. Aberrant microglial activation, however, may contribute to neurodegenerative diseases. Lithospermic acid (LA) is a plant-derived polycyclic phenolic carboxylic acid isolated from Salvia miltiorrhiza. The present study investigated the potential effects of lithospermic acid on LPS-induced neuroinflammation in BV2 microglial cells and determined the mechanism of action of this compound. Cells were pre-treated with lithospermic acid for 1 h and incubated with LPS for 24 h. qPCR, immunofluorescence, and immunoblot assays were used to determine the expression of iNOS, COX2, NF-κB p65, and HSP90 expression. ELISA was employed to measure the production of pro-inflammatory cytokines. Lithospermic acid dramatically reduced LPS-stimulated cell migration and decreased NF-κB p65 nuclear translocation. Furthermore, lithospermic acid also markedly decreased the production of pro-inflammatory cytokines, including IL-6, IL-1β, and TNF-α in a dose-dependent manner. Additionally, lithospermic acid inhibited NO and PGE2 production in response to LPS, and it also inhibited the expression of iNOS and COX2 in a dose-dependent manner. Molecular docking and experimental verification have demonstrated that lithospermic acid inhibits the activity and expression of HSP90. Small interfering RNA knockdown of HSP90 expression, which abrogated LPS-induced inflammation. These findings suggest that the lithospermic acid targeting HSP90 attenuates LPS-induced inflammatory response via the NF-κB signalling pathway in BV2 microglial cells. Collectively, lithospermic acid may offer therapeutic benefits for neurodegenerative disorders associated with microglial activation and could serve as a potential inhibitor/agent for the treatment of neuroinflammation.

Indexed as

Anti-Inflammatory AgentsBenzofuransDepsidesHSP90 Heat-Shock ProteinsInflammationMicrogliaNF-kappa BAnimalsCell LineCytokinesInflammation MediatorsLipopolysaccharidesMiceNitric Oxide Synthase Type IISignal TransductionAnti-Inflammatory AgentsBenzofuransCytokinesDepsidesHSP90 Heat-Shock ProteinsInflammation MediatorsLipopolysaccharidesNF-kappa BNitric Oxide Synthase Type IIAnti-inflammatory effectsBV2 microglial cellsLithospermic acidNF-кB signalling pathway

Identifiers

PMID39969702
PMCPMC11839720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.